- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06221540
The Impact of an Evidence-based Myth-busting Information Intervention on Maternal Food Allergy Related Quality of Life, Anxiety and Self-efficacy
Children with Food Allergy (FA) are at risk of life threatening reactions. They must carry an emergency medicine kit containing adrenaline auto-injector devices for the immediate treatment of anaphylaxis.
Much research has documented the adverse impact of childhood FA on the food allergy related quality of life (FQoL) of the Carer and the family, along with reported higher levels of anxiety and stress. These adverse impacts are largely driven by the need for Carers to always be "emergency ready". Mothers of food allergic children report higher levels of anxiety compared to the rest of the family, possibly due to mothers commonly being the primary care givers responsible for the preparation of meals, childcare etc.
Carers of newly diagnosed food allergic children, looking for more information about their child's FA are at risk of exposure to myths and misinformation about food allergy. These falsehoods are likely to increase further, Carers Food Allergy-related anxiety.
The investigators wish to survey the frequency with which common myths on FA are believed among mothers prior to their attendance at an allergy clinic. They wish to understand the impact of "myth-busting" information on maternal anxiety or self-efficacy when provided to mothers while awaiting a specialist appointment.
The research question is to determine if the online educational session is effective at decreasing anxiety and improving quality of life in Carers of FA children awaiting a specialist appointment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Carers of food allergic children report that their information needs are greatest at the beginning of their journey when their child first experiences a food allergic reaction. Unfortunately, wait times to attend specialist paediatric allergy clinics can be lengthy. Thus, families can experience a prolonged time-gap between the initial allergic reaction and accessing diagnostic testing and benefitting from multi-disciplinary support and education. Furthermore, carers report often contradictory advice from non-specialist Healthcare Professionals (HCPs). This in turn encourages carers to look for information online with many using search engines unless guided to official food allergy websites by HCPs. Not all online information is correct, or evidence based. Often information provided suggests that certain FA children are at greater risk of anaphylaxis and mortality. This in turn increases anxiety amongst carers and impairs their quality of life.
The purpose of this study is to develop an effective intervention that improves maternal FA related quality of life, anxiety, and self-efficacy prior to attending their child's first paediatric allergy clinic appointment. A randomized control trial will be performed comparing quality of life, anxiety and self efficacy in carers who receive the intervention versus those that do not. Participants will be randomized into 2 groups. All volunteers, from both groups, will complete questionnaires online using only a study identifier number. This will ensure anonymity throughout the study. The only personal information that will be asked is the carer's age group, whether they are a mother or father, their child's age and gender and whether they have any other allergies. Group 1 will be sent a written patient information leaflet displaying ten food allergy myths with the myth-busting evidence-based information clearly stated. Two weeks following the online educational session, Groups 1 and 2 will again complete the online questionnaires.
The outcomes are health related quality of life and levels of anxiety. It is hoped that the findings will positively support Carers, children and their families
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Dublin, Ireland
- Children's Health Ireland
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- First referral to Children's Health Ireland allergy service for evaluation of 'Immediate type' IgE food allergy.
- Referral accepted and triaged to a waiting list between 30 months to six months prior to study commencement.
- Child aged between three years and 12 years at the time of study commencement.
Exclusion Criteria:
- Referral source from Children's Health Ireland (CHI) dermatology or immunology services or the patient already attends services that will evaluate food allergy such as CHI dermatology and /or immunology.
- Child younger than three years and older than 12 years at the time of study commencement.
- Referral information is not suggestive of an IgE mediated food allergy.
- Complex referral history suggestive of chronic urticaria, mast cell disorders or eosinophilic oesophagitis.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Received written patient information leaflet
|
A written patient information leaflet displaying ten food allergy myths with the myth-busting evidence-based information clearly stated, focusing on themes pertinent to the myth-busting information
|
No Intervention: Routine education at first clinic appointment
Active Comparator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary Outcome 1
Time Frame: 2 weeks
|
Change in score in each group on Food Allergy Quality of Life Questionnaire (FAQLQ)-Parental Proxy Form
|
2 weeks
|
Primary Outcome 2
Time Frame: 2 weeks
|
Change in score in each group on Food Allergy Independent Measurement (FAIM)
|
2 weeks
|
Primary Outcome 3
Time Frame: 2 weeks
|
Change in score in each group on Food Allergy Anxiety Scale (FAAS)
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Secondary score
Time Frame: 2 weeks
|
Agreement with Food Allergy Myths measured using the Food Allergy Belief (FAB) scale (SEFAQ)
|
2 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Aideen Byrne, PhD, Children's Health Ireland
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GEN/894/21
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Food Allergy
-
Vilnius UniversityEnrolling by invitationFood Allergy in Children | Food Allergy in InfantsLithuania
-
Vilnius UniversityEnrolling by invitationFood Allergy in Children | Food Allergy in InfantsLithuania
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Chinese University of Hong KongRecruiting
-
King's College LondonKing's College Hospital NHS Trust; University College London Hospitals; Cambridge... and other collaboratorsRecruitingEgg Allergy | Food Allergy | Food Allergy in Children | Milk Allergy | Food Allergy in Infants | Nut Allergy | Food Allergen SensitisationUnited Kingdom
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustUnknownEgg Allergy | Food Allergy | Food Allergy in Children | Milk Allergy | Food Allergy in Infants | Nut Allergy | Food Allergen SensitisationUnited Kingdom
-
University Hospital, MontpellierUnknownFood Allergy Suspected | Food Allergy ProvedFrance
-
Stanford UniversityRecruitingFood Allergy | Food Allergy in ChildrenUnited States
-
Rhode Island HospitalCompletedFood Allergy in Children
-
Rhode Island HospitalVirtually Better, Inc.CompletedFood Allergy in Children
Clinical Trials on "Myth busting" information leaflet
-
Hitit UniversityCompletedLow Back Pain | Radiculopathy
-
Oxford University Hospitals NHS TrustLiverpool John Moores University; National Cancer Research NetworkWithdrawn
-
FloralisGroupe Hospitalier Mutualiste de GrenobleCompletedAnkle Sprain | Diverticulitis | Pyelonephritis | Prostatitis | Infectious Colitis | PneumonitisFrance
-
Anglia Ruskin UniversityCambridgeshire and Peterborough NHS Foundation TrustCompleted
-
Maria Sklodowska-Curie National Research Institute...Centre of Postgraduate Medical EducationCompleted
-
Children's Memorial Health Institute, PolandSiemens Healthcare Sp. z o.o.RecruitingDemyelinating Diseases | Urinary Incontinence | Brain Tumor | Headache | Visual Impairment | Growth Deficiency | Psychomotor Retardation, Mild to SeverePoland
-
Famirea Study GroupTerminatedFamily of Dying Patient in the ICU
-
University Hospital, MontpellierRecruitingRheumatoid Arthritis | Psoriatic Arthritis | SpondyloarthritisFrance
-
Gazi UniversityNot yet recruitingAnxiety | Pediatric Anesthesia | Preoperative AnxietyTurkey
-
Tata Memorial HospitalCompleted